Benzodiazepine self-administration in humans and laboratory animals - implications for problems of long-term use and abuse
The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Drug reinforcement may represent the primary behavioral-pharmacological mechanism underlying two types of problematic use of benzodiazepines--recreational abuse by polydrug abusers and inappropriate chronic use by patients. High dose polydrug abuse for the purpose of getting high is readily recognized as a significant social problem. Inappropriate chronic benzodiazepine use is more subtle but relatively common: for anxiolytics, 36% of past-year users (3% of the adult population in the US) report using these drugs for 4 consecutive months or longer. The risks of such long-term use are much better documented than the benefits. This paper provides a current review of various problems that have been identified with the long-term use and the recreational abuse of benzodiazepines, including memory impairment, risk of accidents, falls and hip fractures in the elderly, a withdrawal syndrome, brain damage, overuse in the elderly, overuse by chronic pain patients, overuse by alcoholics and recreational abuse among alcoholics and polydrug abusers. A comprehensive review of the literature on benzodiazepine reinforcing effects in humans and laboratory animals is also provided. Drug self-administration studies in humans and laboratory animals provide models of both types of problematic benzodiazepine use. Recreational abuse of benzodiazepines has been modeled in human research with polydrug abusers and in laboratory animal studies, which show that the reinforcing effect of benzodiazepines is intermediate relative to other sedative compounds and is increased in subjects with histories of previous sedative drug self-administration. The problem of inappropriate long-term use of benzodiazepines by people without histories of drug abuse has been partially modeled in human studies showing that benzodiazepines function as reinforcers in subjects with anxiety, insomnia, and histories of moderate alcohol consumption, and in preclinical studies showing stable, low-rate benzodiazepine self-injection with concurrent physical dependence under conditions of continuous availability. Both human and animal research suggests that the drug history and current behavioral context may be important in the establishment of benzodiazepines as reinforcers. Limited human and animal research provides little support for the common belief that physical dependence enhances benzodiazepine reinforcement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although most patients taking BZDs as prescribed will not develop BZD use disorder, the risk of physical dependence and BZD use disorder increases with time, particularly in patients who use alcohol or other substances.31”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [31]
In the citing paper
“Thus, it is important to note that, even though zolpidem does not seem to engender any obvious tolerance development, zolpidem can lead to withdrawal symptoms that are comparable to those seen after chronic classical benzodiazepine treatment [29, 77].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [77]
Citations
Cites
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,000
American drinking practices : a national study of drinking behavior and attitudes
Cahalan, D., Cisin, I. H., & Crossley, H. M. (1969) · Medical Entomology and Zoology · Cited by 637
Benzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560
Benzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548
Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers
Ray, W. A., Fought, R. L., & Decker, M. D. (1992) · American Journal of Epidemiology · doi:10.1093/aje/136.7.873 · Cited by 417
Benzodiazepines, memory and mood: a review
Valerie Curran, H. (1991) · Psychopharmacology · doi:10.1007/bf02316856 · Cited by 401
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels, K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220015002 · Cited by 332
Goa, K. L., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632020-00002 · Cited by 332
Cited by
Items 201–262 of 262
Medical Complications of Drug Abuse
Benowitz, N. L. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch8 · Cited by 2
Benowitz, N., & Zevin, S. (2007) · CRC Press eBooks · doi:10.1201/9781420054446.ch8 · Cited by 2
Barbiturates and Other Hypnotics and Sedatives
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50010-6 · Cited by 2
Investigation of preference for nightly triazolam versus placebo in moderate social alcohol drinkers
Mintzer, M. Z., Allen, R. P., & Griffiths, R. R. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500101 · Cited by 2
Self-citationPreclinical abuse potential assessment of the anticonvulsant zonisamide
Wiley, J. L., Patrick, G. A., Dance, M. E., Meyer, K. B., & Balster, R. L. (2001) · Drug Development Research · doi:10.1002/ddr.1206 · Cited by 2
Benzodiazepine discontinuation treatment in outpatients with complicated dependence
Vorma, H. (2003) · Helda - University of Helsinki Institutional Repository · Cited by 3
Preclinical evidence for a novel pharmacotherapeutic approach for treating benzodiazepine addiction
Berro, L. F., Cook, J. E., Moreira-Junior, E. D. C., Hembree, H. L., Comfort, V. L., Rüedi‐Bettschen, D., Platt, D. M., & Rowlett, J. K. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03762-0 · Cited by 1
Riemann, D. W., Baglioni, C., Nissen, C., Nevière, A., Irfan, O., Nouveau, P. L., Leontiou, C., & Léger, D. (2026) · Journal of Sleep Research · doi:10.1111/jsr.70352 · Cited by 1
Abuse liability of intra-nasal midazolam in inhaled-cocaine abusers
Braun, I. M., Tavares, H., Nucci, G. D., & Bernik, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.05.006 · Cited by 1
Insomnia: assessment and treatment review
Qazi, F. M., & Schluederberg, E. A. (2012) · Osteopathic Family Physician · doi:10.1016/j.osfp.2012.03.002 · Cited by 1
Kim, T. E., Jung, J. H., Yoon, S., & Kim, S. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i5.8 · Cited by 1
Drug Abuse, Dependency, and Withdrawal
Kay, A. L., Stober, K. R., Serota, R. D., & Weinstein, S. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1703-7.10060-x · Cited by 1
Vogel, M., & Caflisch, C. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00014-x · Cited by 2
Wu, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47904-2.00037-4 · Cited by 1
Stanos, S. P., Tyburski, M. D., & Harden, R. N. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0884-4.10042-4 · Cited by 1
Substance Use Disorders: A Biopsychosocial Perspective
Duncan, P. M. (2020) · ODU Digital Commons (Old Dominion University) · Cited by 3
Galea, M. (2008) · Victoria University Research Repository (Victoria University) · Cited by 5
Abuse and Dependence Liability of GABAA-Receptor Modulators
Rowlett, J. K., Duke, A. N., & Platt, D. M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-465-0_7 · Cited by 1
Wright, B. T. (2016) · doi:10.21007/etd.cghs.2016.0408 · Cited by 2
Vogel, M., & Caflisch, C. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21074-7.00017-4 · Cited by 2
Drug-induced synaptic plasticity in addiction : the mesolimbic dopamine pathway and benzodiazepines
Panhelainen, A. E. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 1
Benzodiazepines and related drugs for older depressed people
Hao, Q., Dong, B. R., Huang, C. Q., & Wu, T. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008620
RetractedPotencial de abuso do midazolam intranasal em usuários de cocaína aspirada e voluntários normais
Braun, I. M. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-28112012-124456
Problematisch middelengebruik onder ouderen en omgang daarmee door hulpverleners
Konijnendijk, A. (2007)
Xiang, K. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Abrahamsson, T. (2016) · Lund University Publications (Lund University)
Tietz, E. I. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00029-9
Social Defeat Stress Causes a Switch in the Neural Systems Mediating Benzodiazepine Motivation
Doss, L. (2011) · TSpace (University of Toronto)
Addictive medication in relation to drug treatment and overdose death
Tjagvad, C. (2016) · NORA - Norwegian Open Research Archives
Wadji, F. B. (2013) · TSpace (University of Toronto)
Prescribing and Dispensing of Benzodiazepines
Islam, M. M., Nielsen, S., McRae, I., Haber, P., Demirkol, A., Murnion, B. P., Wilson, H. H., & Conigrave, K. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00028-7 · Cited by 2
Diazepam Withdrawal Expression is related to Hippocampal NOS-1 Upregulation
de la Villarmois, E. A., Constantin, M. F., Bregonzio, C., & Pérez, M. F. (2018) · Archives of Pharmacy and Pharmaceutical Sciences · doi:10.29328/journal.hps.1001006
Integrative Approach to Sedative-Hypnotic Use Disorder
Rees, G., Shapiro, B., & Torrington, M. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780190275334.003.0005
Shin, K., Kobayashi, D., Kawashiri, T., Ikari, K., Mitsuyasu, H., Murakami, T., Tsutsumi, K., Kanazawa, Y., Kamimura, H., & Shimazoe, T. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00087
Prescription Drug Abuse: Risks, Diversion, and Prevention
Bramness, J. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_22 · Cited by 1
Psychiatric Disorders, Personality, and Developmental Factors
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.009
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.015
Use Disorders of Cocaine and Methamphetamine
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.014
Tranquilizers and Sedative Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.016
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.018
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.001
The Biopsychosocial Perspective and Research Methods for Investigation of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.002
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.010
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.004
Genetic Influence on Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.007
Brain Function and Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.006
Tobacco Use and Nicotine Addiction
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.012
Behavioral, Cognitive, and Social Factors Promoting SUD
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.008
Psychopharmacology: Drug Effects on Brain Function
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.005
Diagnosis of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.003
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.011
Treatment of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.017
Rowlett, J. K. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717948626.793456610
Discriminative stimulus and reinforcing effects of diclazepam in rodents
Lee, W., Lee, J. W., Kim, S., Kim, J. M., Youn, D.-H., Park, S. H., Kwon, C., & Choi, S.-O. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173687
Nahas-Vigon, J. H., & Fingerhood, M. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197796207.003.0005
Barbituriques et autres hypnotiques et sédatifs
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50006-1
Tengsl vímuefnaneyslu unglinga við fjölda vina þeirra sem neytt hafa sömu vímuefna
1987, G. L. Þ. (2014) · Skemman
Henningfield, J. E., Barrett, F. S., Evans, S. M., Garcia‐Romeu, A., Garrett, B. E., Hienz, R. D., Lukas, S. E., Nayak, S. M., Strain, E. C., Weerts, E. M., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251398801 · Cited by 1
Self-citationBramness, J. G. (2026) · Springer eBooks · doi:10.1007/978-3-032-20049-5_6 · Cited by 1
Song, Z.-P., Li, N.-C., Song, R., Zheng, C., Wang, C., Liao, F., Tang, S.-S., Yuan, D.-H., Hong, H., Chen, Z., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01909-3
Earl, D. E. (2011) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Metadata
- Authors
- Griffiths, R. R., & Weerts, E. M.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Psychopharmacology
- Published
- 1997-11-03
- Volume
- 134
- Issue
- 1
- Pages
- 1-37
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2038299708
- Cited by
- 260
- References
- 205
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 27 · 2019: 7 · 2018: 5 · 2017: 7 · 2016: 13 · 2015: 7 · 2014: 12 · 2013: 9 · 2012: 16
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Institutes of Health (5r01da001147-28)
- National Institute on Drug Abuse (R01DA003889, R01 DA01147, R01DA03889)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepines, self-administration, drug reinforcement, recreational drug abuse, polydrug abuse, memory impairment, benzodiazepine withdrawal syndrome, physical dependence, chronic pain patients, alcoholics, sedatives, anxiolytics, insomnia
- MeSH terms
- Animals, Benzodiazepines, Humans, Self Administration, Anti-Anxiety Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.